Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists
摘要:
A novel series of indolyl and dihydroindolyl glycinamides were identified as potent NPY5 antagonists with in vivo activity from screen hit 1. The dihydroindolyl glycinamide 10a significantly inhibits NPY5 agonist induced feeding at a dose of 0.1 mg/kg. The indolyl glycinamide 12c also inhibits NPY5 agonist induced feeding at a dose of 1 mg/kg. Both compounds 10a and 12c represent potential tools for further investigation into the biology of the NPY5 receptor. (C) 2012 Elsevier Ltd. All rights reserved.
Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists
摘要:
A novel series of indolyl and dihydroindolyl glycinamides were identified as potent NPY5 antagonists with in vivo activity from screen hit 1. The dihydroindolyl glycinamide 10a significantly inhibits NPY5 agonist induced feeding at a dose of 0.1 mg/kg. The indolyl glycinamide 12c also inhibits NPY5 agonist induced feeding at a dose of 1 mg/kg. Both compounds 10a and 12c represent potential tools for further investigation into the biology of the NPY5 receptor. (C) 2012 Elsevier Ltd. All rights reserved.
[EN] PIPERAZINE DERIVATIVE RENIN INHIBITORS<br/>[FR] DERIVES DE PIPERAZINE AGISSANT COMME INHIBITEURS DE LA RENINE
申请人:WARNER LAMBERT CO
公开号:WO2004089915A1
公开(公告)日:2004-10-21
Disclosed are piperazine derivatives, their manufacture and use as inhibitors of renin. Formula (I):
揭示了哌嗪衍生物,它们的制备以及作为肾素抑制剂的用途。化学式(I):
Piperazine derivative renin inhibitors
申请人:——
公开号:US20040214832A1
公开(公告)日:2004-10-28
Disclosed are piperazine derivatives, their manufacture and use as inhibitors of renin.
本发明涉及哌嗪衍生物,它们的制备和用途作为肾素抑制剂。
Zinner,H. et al., Journal fur praktische Chemie (Leipzig 1954), 1966, vol. 33, p. 130 - 138
作者:Zinner,H. et al.
DOI:——
日期:——
US7244763B2
申请人:——
公开号:US7244763B2
公开(公告)日:2007-07-17
Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists
作者:Lingyun Wu、Kai Lu、Mathivanan Packiarajan、Vrej Jubian、Gamini Chandrasena、Toni C. Wolinsky、Mary W. Walker
DOI:10.1016/j.bmcl.2012.01.117
日期:2012.3
A novel series of indolyl and dihydroindolyl glycinamides were identified as potent NPY5 antagonists with in vivo activity from screen hit 1. The dihydroindolyl glycinamide 10a significantly inhibits NPY5 agonist induced feeding at a dose of 0.1 mg/kg. The indolyl glycinamide 12c also inhibits NPY5 agonist induced feeding at a dose of 1 mg/kg. Both compounds 10a and 12c represent potential tools for further investigation into the biology of the NPY5 receptor. (C) 2012 Elsevier Ltd. All rights reserved.